These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16080512

  • 1. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.
    Ghirardi O, Lo Giudice P, Pisano C, Vertechy M, Bellucci A, Vesci L, Cundari S, Miloso M, Rigamonti LM, Nicolini G, Zanna C, Carminati P.
    Anticancer Res; 2005; 25(4):2681-7. PubMed ID: 16080512
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.
    Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G.
    Clin Cancer Res; 2003 Nov 15; 9(15):5756-67. PubMed ID: 14654561
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine.
    Ghirardi O, Vertechy M, Vesci L, Canta A, Nicolini G, Galbiati S, Ciogli C, Quattrini G, Pisano C, Cundari S, Rigamonti LM.
    In Vivo; 2005 Nov 15; 19(3):631-7. PubMed ID: 15875786
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
    Ushio S, Egashira N, Sada H, Kawashiri T, Shirahama M, Masuguchi K, Oishi R.
    Eur J Cancer; 2012 Jun 15; 48(9):1407-13. PubMed ID: 21907570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
    De Grandis D.
    CNS Drugs; 2007 Jun 15; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
    [Abstract] [Full Text] [Related]

  • 8. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R, Brines M, Lauria G, Savino C, Gilardini A, Nicolini G, Rodriguez-Menendez V, Oggioni N, Canta A, Penza P, Lombardi R, Minoia C, Ronchi A, Cerami A, Ghezzi P, Cavaletti G.
    Clin Cancer Res; 2006 Apr 15; 12(8):2607-12. PubMed ID: 16638873
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol.
    Binienda ZK, Beaudoin MA, Gough B, Ali SF, Virmani A.
    Neurosci Lett; 2010 Aug 16; 480(2):117-21. PubMed ID: 20542088
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
    Nishida K, Takeuchi K, Hosoda A, Sugano S, Morisaki E, Ohishi A, Nagasawa K.
    Life Sci; 2018 Aug 15; 207():516-524. PubMed ID: 29981320
    [Abstract] [Full Text] [Related]

  • 13. Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.
    Garg MB, Ackland SP.
    Cancer Chemother Pharmacol; 2011 Apr 15; 67(4):963-6. PubMed ID: 20976600
    [Abstract] [Full Text] [Related]

  • 14. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
    Cavaletti G, Petruccioli MG, Marmiroli P, Rigolio R, Galbiati S, Zoia C, Ferrarese C, Tagliabue E, Dolci C, Bayssas M, Griffon Etienne G, Tredici G.
    Anticancer Res; 2002 Apr 15; 22(6C):4199-204. PubMed ID: 12553056
    [Abstract] [Full Text] [Related]

  • 15. Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism.
    Bagetta V, Barone I, Ghiglieri V, Di Filippo M, Sgobio C, Bernardi G, Calabresi P, Picconi B.
    Neuropharmacology; 2008 Aug 15; 55(2):223-9. PubMed ID: 18590920
    [Abstract] [Full Text] [Related]

  • 16. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
    Lersch C, Schmelz R, Eckel F, Erdmann J, Mayr M, Schulte-Frohlinde E, Quasthoff S, Grosskreutz J, Adelsberger H.
    Clin Colorectal Cancer; 2002 May 15; 2(1):54-8. PubMed ID: 12453338
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons.
    Epis R, Marcello E, Gardoni F, Longhi A, Calvani M, Iannuccelli M, Cattabeni F, Canonico PL, Di Luca M.
    Eur J Pharmacol; 2008 Nov 12; 597(1-3):51-6. PubMed ID: 18801359
    [Abstract] [Full Text] [Related]

  • 18. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S.
    Ann Pharmacother; 2008 Oct 12; 42(10):1481-5. PubMed ID: 18698011
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.
    Rodriguez-Menendez V, Gilardini A, Bossi M, Canta A, Oggioni N, Carozzi V, Tremolizzo L, Cavaletti G.
    Anticancer Res; 2008 Oct 12; 28(1A):335-42. PubMed ID: 18383866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.